Patents Assigned to EDGEMONT PHARMACEUTICALS, LLC TRUST
  • Alcohol-resistant oral pharmaceutical compositions of lorazepam
    Patent number: 11806433
    Abstract: Described herein are alcohol-resistant oral pharmaceutical compositions and dosage forms that exhibit reduced drug release in the presence of alcohol. The compositions comprise a substrate comprising a controlled release formulation of lorazepam and an alcohol-resistant coating surrounding the substrate.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: November 7, 2023
    Assignee: EDGEMONT PHARMACEUTICALS, LLC TRUST
    Inventors: Douglas Saltel, Michael Vachon